PReS-FINAL-2172: Efficacy of corticosteroids and intravenous cyclophosphamide for patients with juvenile systemic sclerosis

Lignende værker

• PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy
  af: Sato, T, et al.
  Udgivet: (2013)
• PReS-FINAL-2189: Tocillizumab for patients with takayasu arteritis in childhood refractory to conventional therapy
  af: Yamazaki, K, et al.
  Udgivet: (2013)
• PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan
  af: Yokota, S, et al.
  Udgivet: (2013)
• PReS-FINAL-2130-A: Effectiveness of intravenous cyclophosphamide in severe or refractory juvenile dermatomyositis - a national cohort study UK and Ireland
  af: Moraitis, E, et al.
  Udgivet: (2013)
• PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
  af: Bellutti Enders, F, et al.
  Udgivet: (2013)